In adult AML patients, IDH1 and IDH2 mutations are usually mutually exclusive with TET2 mutations; however, in older AML patients, it is more frequent to observe an IDH/TET2 co-mutation pattern [54]. Here, TET2 is linked to acute myeloid leukemia.